Similar articles

• Tranexamic acid in the preoperative management of ruptured intracranial aneurysms.

  Fodstad H, Liliequist B, Schannong M, Thulin CA. Fodstad H, et al. Surg Neurol. 1978 Jul;10(1):9-15. Surg Neurol. 1978. PMID: 356311 Clinical Trial.
• Determination of tranexamic acid (AMCA) and fibrin/fibrinogen degradation products in cerebrospinal fluid after aneurysmal subarachnoid haemorrhage.

  Fodstad H, Pilbrant A, Schannong M, Strömberg S. Fodstad H, et al. Acta Neurochir (Wien). 1981;58(1-2):1-13. doi: 10.1007/BF01401679. Acta Neurochir (Wien). 1981. PMID: 7282453
• The use of antifibrinolytic drugs in aneurysmal subarachnoid hemorrhage.

  Schisano G. Schisano G. Surg Neurol. 1978 Oct;10(4):217-22. Surg Neurol. 1978. PMID: 725719
• Antifibrinolytic therapy in subarachnoid hemorrhage caused by ruptured intracranial aneurysm.

  Ramirez-Lassepas M. Ramirez-Lassepas M. Neurology. 1981 Mar;31(3):316-22. doi: 10.1212/wnl.31.3.316. Neurology. 1981. PMID: 7010208 Review.
• Current status of antifibrinolytic therapy for treatment of patients with aneurysmal subarachnoid hemorrhage.

  Adams HP Jr. Adams HP Jr. Stroke. 1982 Mar-Apr;13(2):256-9. doi: 10.1161/01.str.13.2.256. Stroke. 1982. PMID: 7039006 Review. No abstract available.